RCKT Cash-Secured Put Strategy
RCKT (Rocket Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at specific genetic conditions: Fanconi anemia, characterized by a bone marrow defect that hinders blood cell production; leukocyte adhesion deficiency-I, an inherited disorder resulting in a compromised immune system; and pyruvate kinase deficiency, a rare autosomal recessive red blood cell ailment leading to chronic non-spherocytic hemolytic anemia. Complementing these, Rocket Pharmaceuticals also has an in vivo adeno-associated virus program underway for Danon disease, a serious multi-organ lysosomal storage disorder that tragically often results in early mortality due to heart failure. To facilitate its extensive research and development efforts, the company has established key licensing partnerships with esteemed institutions such as the Fred Hutchinson Cancer Research Center, European research bodies including CIEMAT and its collaborators (Centro de Investigacion Biomedica En Red and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz), UCL Business PLC (in conjunction with CIEMAT), The Regents of the University of California, and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. maintains its primary corporate location in Cranbury, New Jersey.
RCKT (Rocket Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $354.9M, a beta of 0.47 versus the broader market, a 52-week range of 2.4-5.45, average daily share volume of 3.1M, a public-listing history dating back to 2015, approximately 299 full-time employees. These structural characteristics shape how RCKT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.47 indicates RCKT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a cash-secured put on RCKT?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current RCKT snapshot
As of June 29, 2026, spot at $3.37, ATM IV 79.60%, IV rank 13.79%, expected move 22.82%. The cash-secured put on RCKT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this cash-secured put structure on RCKT specifically: RCKT IV at 79.60% is on the cheap side of its 1-year range, which means a premium-selling RCKT cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 22.82% (roughly $0.77 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RCKT expiries trade a higher absolute premium for lower per-day decay. Position sizing on RCKT should anchor to the underlying notional of $3.37 per share and to the trader's directional view on RCKT stock.
RCKT cash-secured put setup
The RCKT cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RCKT near $3.37, the first option leg uses a $3.20 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RCKT chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RCKT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $3.20 | N/A |
RCKT cash-secured put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
RCKT cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on RCKT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use cash-secured put on RCKT
Cash-secured puts on RCKT earn premium while a trader waits to acquire RCKT stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RCKT.
RCKT thesis for this cash-secured put
The market-implied 1-standard-deviation range for RCKT extends from approximately $2.60 on the downside to $4.14 on the upside. A RCKT cash-secured put lets a trader earn premium while waiting to acquire RCKT at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current RCKT IV rank near 13.79% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RCKT at 79.60%. As a Healthcare name, RCKT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RCKT-specific events.
RCKT cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RCKT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RCKT alongside the broader basket even when RCKT-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on RCKT carry tail risk when realized volatility exceeds the implied move; review historical RCKT earnings reactions and macro stress periods before sizing. Always rebuild the position from current RCKT chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on RCKT?
- A cash-secured put on RCKT is the cash-secured put strategy applied to RCKT (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With RCKT stock trading near $3.37, the strikes shown on this page are snapped to the nearest listed RCKT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are RCKT cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the RCKT cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 79.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RCKT cash-secured put?
- The breakeven for the RCKT cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RCKT market-implied 1-standard-deviation expected move is approximately 22.82%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on RCKT?
- Cash-secured puts on RCKT earn premium while a trader waits to acquire RCKT stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RCKT.
- How does current RCKT implied volatility affect this cash-secured put?
- RCKT ATM IV is at 79.60% with IV rank near 13.79%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.